Biocon fell 1.84% to Rs 994.40 at 14:45 IST on BSE on profit booking after gaining 8.26% in prior three sessions.
Shares of Biocon had jumped 8.26% in three sessions to settle at Rs 1,013 yesterday, 9 January 2017, from a close of Rs 935.65 on 4 January 2017.
Meanwhile, the S&P BSE Sensex was up 156.03 points or 0.58% at 26,882.06.
More than usual volumes were witnessed on the counter. On the BSE, 1.01 lakh shares were traded in the counter so far as against average daily volume of 75,444 shares in the past one quarter. The stock had hit a high of Rs 1,026 so far during the day, which is also a record high for the stock. The stock had hit a low of Rs 992.50 so far during the day. The stock had hit a 52-week low of Rs 430.80 on 12 February 2016.
The stock had outperformed the market over the past one month till 9 January 2017, gaining 7.39% compared with the Sensex's 0.08% fall. The scrip had also outperformed the market in past one quarter, rising 7.32% as against the Sensex's 4.76% fall.
The large-cap company has equity capital of Rs 100 crore. Face value per share is Rs 5.
Biocon reported consolidated net profit of Rs 146.70 crore in Q2 September 2016 as compared with net loss of Rs 10.60 crore in Q2 September 2015. The consolidated net sales rose 19.9% to Rs 932.10 crore in Q2 September 2016 over Q2 September 2015. The company will announce its Q3 results on 24 January 2017.
Biocon is India's largest and fully-integrated, innovation-led biopharmaceutical company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
